US$ 24.34
glp-1 coverage Who Gets the Shot? Access by State Who Gets the Shot? GLP-1
Description
When employees would trade vacation time, remote work days, or even part of their bonus for GLP-1s, there should be real consideration for plans which is a better investment for their business

Risk of bias: all four RCTs were rated low risk by RoB2 (with some concerns for open-label outcome ascertainment in three trials, a domain-specific issue that does not alter the overall RoB2 category from low)

Eli Lilly (NYSE:LLY) plans to invest over US$3.5b in a new Pennsylvania manufacturing facility focused on next generation injectable weight loss therapies
Epub 2024 Feb 5
